Literature DB >> 3652420

Hierarchy of levels of ischemia-induced impairment in regional left ventricular systolic function in man.

A M Zeiher1, H Wollschlaeger, T Bonzel, W Kasper, H Just.   

Abstract

We tested the hypothesis that different subsets of ischemia-induced wall motion disorders are characterized by specific patterns of abnormal regional left ventricular systolic function. Regional contraction was quantitatively assessed from two-dimensional echocardiograms by an automated integrative analysis considering the time course of wall motion during the entire contraction sequence in 20 patients with chronic myocardial infarction, in 13 patients with impending myocardial infarction (less than 2 hr after the onset of symptoms), and in nine patients during transient myocardial ischemia. Wall motion abnormalities were detected in all patients by the integrative analysis. In contrast, the sensitivity for detecting wall motion abnormalities was 80% during chronic infarction, 77% during impending infarction, and 56% during transient ischemia if only end-diastolic and end-systolic frames were compared for assessment of overall regional systolic function. There were distinct differences in the time course of abnormal wall excursion between the three groups. Chronic infarction was characterized by a monophasic contraction pattern, with abnormal synergy in regional contractile events occurring predominantly during early systole. In contrast, transient ischemia caused predominantly mid-to-late systolic abnormal synergy followed by late systolic shortening corresponding to a polyphasic contraction pattern. During impending infarction, an intermediate temporal contraction pattern was present with both early and mesosystolic abnormal synergy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3652420     DOI: 10.1161/01.cir.76.4.768

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Between observer variation is not eliminated by standardised analysis of dobutamine-atropine stress echocardiography.

Authors:  Steen Carstensen; Henning Bundgaard; Lars Kjøller-Hansen; Dan Atar; Samir M Ali; Kari Saunamäki; Henning Kelbaek
Journal:  Int J Cardiovasc Imaging       Date:  2002-06       Impact factor: 2.357

Review 2.  Echocardiographic insights into regional flow-function relationships in coronary artery disease.

Authors:  Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 3.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

4.  How does computer-assisted digital wall motion analysis influence observer agreement and diagnostic accuracy during stress echocardiography?

Authors:  K Bjørnstad; S Aakhus; H G Torp
Journal:  Int J Card Imaging       Date:  1997-04

5.  Quantification of Contraction Synchronicity and Contraction Work in Coronary Artery Disease.

Authors:  Takanaga Niimi; Mamoru Nanasato; Hisatoshi Maeda
Journal:  Nucl Med Mol Imaging       Date:  2017-02-02

6.  Potential Linkage between High Normalized Electromechanical Activation Time (EMAT), an Early Systolic Time Interval Abnormality with Metabolic Syndrome.

Authors:  Kai-Hung Cheng; Jiun-Hung Geng; Cheng-Hsueh Lee; Chia-Chu Liu; Chao-Ping Wang; Shu-Pin Huang
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

7.  Dynamic analysis of left-ventricular shape based on curvature function.

Authors:  M Halmann; S Sideman; H Azhari; W Markiewitz; R Beyar
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

8.  Early Systolic Lengthening in Patients With ST-Segment-Elevation Myocardial Infarction: A Novel Predictor of Cardiovascular Events.

Authors:  Philip Brainin; Sune Haahr-Pedersen; Flemming Javier Olsen; Anna Engell Holm; Thomas Fritz-Hansen; Thomas Jespersen; Gunnar Gislason; Tor Biering-Sørensen
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.